Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

MEDICAL ALGORITHM: Diagnosis and Treatment of Eosinophilic Esophagitis in Adults.

Greuter T, Straumann A.

Allergy. 2019 Nov 12. doi: 10.1111/all.14112. [Epub ahead of print]

PMID:
31714997
2.

Reply.

Greuter T, Schoepfer AM, Straumann A.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2385-2386. doi: 10.1016/j.cgh.2019.04.054. No abstract available.

PMID:
31543240
3.

Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab.

Grandinetti T, Biedermann L, Bussmann C, Straumann A, Hruz P.

Dig Dis Sci. 2019 Aug;64(8):2231-2241. doi: 10.1007/s10620-019-05617-3. Epub 2019 Apr 13.

PMID:
30982212
4.

Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.

Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J, Hartmann D, Bredenoord AJ, Ciriza de Los Rios C, Schubert S, Brückner S, Madisch A, Hayat J, Tack J, Attwood S, Mueller R, Greinwald R, Schoepfer A, Straumann A; International EOS-1 Study Group.

Gastroenterology. 2019 Jul;157(1):74-86.e15. doi: 10.1053/j.gastro.2019.03.025. Epub 2019 Mar 26.

5.

Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use.

Greuter T, Alexander JA, Straumann A, Katzka DA.

Clin Transl Gastroenterol. 2018 Dec;9(12):e212. doi: 10.1038/s41424-018-0074-8. Review.

6.

Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.

Schoepfer AM, Hirano I, Coslovsky M, Roumet MC, Zwahlen M, Kuehni CE, Hafner D, Alexander JA, Dellon ES, Gonsalves N, Leung J, Bussmann C, Collins MH, Newbury RO, Smyrk TC, Woosley JT, Yang GY, Romero Y, Katzka DA, Furuta GT, Gupta SK, Aceves SS, Chehade M, Spergel JM, Falk GW, Meltzer BA, Comer GM, Straumann A, Safroneeva E; International EEsAI Study Group.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1477-1488.e10. doi: 10.1016/j.cgh.2018.11.032. Epub 2018 Nov 23.

PMID:
30476587
7.

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.

Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, Straumann A, Safroneeva E, Grimm M, Smith H, Tompkins CA, Woo A, Peach R, Frohna P, Gujrathi S, Penenberg DN, Li C, Opiteck GJ, Olson A, Aranda R, Rothenberg ME, Dellon ES; HEROES Study Group.

Gastroenterology. 2019 Feb;156(3):592-603.e10. doi: 10.1053/j.gastro.2018.10.051. Epub 2018 Nov 2.

8.

Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis.

Kia L, Nelson M, Zalewski A, Gregory D, Gonsalves N, Straumann A, Hirano I.

Dis Esophagus. 2018 Dec 1;31(12). doi: 10.1093/dote/doy098.

PMID:
30380044
9.

Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes.

Safroneeva E, Balsiger L, Hafner D, Kuehni CE, Zwahlen M, Trelle S, Godat S, Biedermann L, Greuter T, Vavricka S, Straumann A, Schoepfer AM.

Aliment Pharmacol Ther. 2018 Nov;48(10):1082-1090. doi: 10.1111/apt.15000.

PMID:
30375682
10.

Medical and dietary treatments in eosinophilic esophagitis.

Biedermann L, Straumann A.

Curr Opin Pharmacol. 2018 Dec;43:139-144. doi: 10.1016/j.coph.2018.08.013. Epub 2018 Oct 16. Review.

PMID:
30336406
11.

Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.

Scharl S, Barthel C, Rossel JB, Biedermann L, Misselwitz B, Schoepfer AM, Straumann A, Vavricka SR, Rogler G, Scharl M, Greuter T.

Am J Gastroenterol. 2019 Jan;114(1):116-126. doi: 10.1038/s41395-018-0360-9.

PMID:
30333538
12.

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course.

Greuter T, Piller A, Fournier N, Safroneeva E, Straumann A, Biedermann L, Godat S, Nydegger A, Scharl M, Rogler G, Vavricka SR, Schoepfer AM; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2018 Nov 28;12(12):1399-1409. doi: 10.1093/ecco-jcc/jjy121.

PMID:
30165603
13.

Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

Safroneeva E, Saner C, Rossel JB, Golay D, Pittet V, Godat S, Diem S, Aepli P, Sawatzki M, Borovicka J, Burgmann K, Juillerat P, Netzer P, Sendensky A, Hruz P, Girardin M, Biedermann L, Greuter T, Vavricka S, Michetti P, Mueller C, Straumann A, Schoepfer AM; Swiss EoE Cohort Study Group.

Inflamm Intest Dis. 2018 Mar;2(3):163-170. doi: 10.1159/000486131. Epub 2018 Jan 31.

14.

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ.

Gastroenterology. 2018 Oct;155(4):1022-1033.e10. doi: 10.1053/j.gastro.2018.07.009. Epub 2018 Sep 6. Review.

15.

Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review.

Ma C, van Rhijn BD, Jairath V, Nguyen TM, Parker CE, Aceves SS, Furuta GT, Gupta SK, Katzka DA, Safroneeva E, Schoepfer AM, Straumann A, Spergel JM, Pai RK, Feagan BG, Hirano I, Dellon ES, Bredenoord AJ.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1714-1729.e3. doi: 10.1016/j.cgh.2018.06.005. Epub 2018 Jun 14.

16.

Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients.

Greuter T, Safroneeva E, Bussmann C, Biedermann L, Vavricka SR, Katzka DA, Schoepfer AM, Straumann A.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):419-428.e6. doi: 10.1016/j.cgh.2018.05.045. Epub 2018 Jun 11.

17.

Eosinophilic oesophagitis: relevance of mast cell infiltration.

Strasser DS, Seger S, Bussmann C, Pierlot GM, Groenen PMA, Stalder AK, Straumann A.

Histopathology. 2018 Sep;73(3):454-463. doi: 10.1111/his.13653. Epub 2018 Jun 22.

PMID:
29772120
18.

Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review.

Hines BT, Rank MA, Wright BL, Marks LA, Hagan JB, Straumann A, Greenhawt M, Dellon ES.

Ann Allergy Asthma Immunol. 2018 Aug;121(2):218-228. doi: 10.1016/j.anai.2018.05.005. Epub 2018 May 16.

19.

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn's disease patients.

Greuter T, Franc Y, Kaelin M, Schoepfer AM, Schreiner P, Zeitz J, Scharl M, Misselwitz B, Straumann A, Vavricka SR, Rogler G, von Känel R, Biedermann L.

Therap Adv Gastroenterol. 2018 Feb 19;11:1756283X18757715. doi: 10.1177/1756283X18757715. eCollection 2018.

20.

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.

Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):612-620. doi: 10.1097/MEG.0000000000001078.

21.

Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms.

Schoepfer AM, Simko A, Bussmann C, Safroneeva E, Zwahlen M, Greuter T, Biedermann L, Vavricka S, Godat S, Reinhard A, Saner C, Maye H, Sempoux C, Brunel C, Blanchard C, Simon D, Simon HU, Straumann A.

Am J Gastroenterol. 2018 Mar;113(3):348-357. doi: 10.1038/ajg.2017.493. Epub 2018 Jan 16.

PMID:
29336433
22.

Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Cheng K, Gupta SK, Kantor S, Kuhl JT, Aceves SS, Bonis PA, Capocelli KE, Carpenter C, Chehade M, Collins MH, Dellon ES, Falk GW, Gopal-Srivastava R, Gonsalves N, Hirano I, King EC, Leung J, Krischer JP, Mukkada VA, Schoepfer A, Spergel JM, Straumann A, Yang GY, Furuta GT, Rothenberg ME.

Transl Sci Rare Dis. 2017 Dec 18;2(3-4):141-155. doi: 10.3233/TRD-170016.

23.

Eosinophiler Granulozyt – manchmal Freund, manchmal Feind.

Straumann A.

Ther Umsch. 2017 Nov;74(6):289. doi: 10.1024/0040-5930/a000916. German. No abstract available.

PMID:
29160754
24.

Pharmacologic Treatment of Eosinophilic Esophagitis: An Update.

Schoepfer AM, Straumann A, Safroneeva E.

Gastrointest Endosc Clin N Am. 2018 Jan;28(1):77-88. doi: 10.1016/j.giec.2017.07.007. Epub 2017 Oct 7. Review.

PMID:
29129301
25.

Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis.

Safroneeva E, Straumann A, Schoepfer AM.

Gastrointest Endosc Clin N Am. 2018 Jan;28(1):35-45. doi: 10.1016/j.giec.2017.08.001. Review.

PMID:
29129298
26.

Current concepts in eosinophilic esophagitis.

Simon D, Straumann A, Schoepfer AM, Simon HU.

Allergo J Int. 2017;26(7):258-266. doi: 10.1007/s40629-017-0037-8. Epub 2017 Sep 13. Review.

27.

Diagnosis and Treatment of Eosinophilic Esophagitis.

Straumann A, Katzka DA.

Gastroenterology. 2018 Jan;154(2):346-359. doi: 10.1053/j.gastro.2017.05.066. Epub 2017 Jul 27. Review.

PMID:
28756235
28.

Long-Term Treatment of Eosinophilic Esophagitis With Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept.

Greuter T, Bussmann C, Safroneeva E, Schoepfer AM, Biedermann L, Vavricka SR, Straumann A.

Am J Gastroenterol. 2017 Oct;112(10):1527-1535. doi: 10.1038/ajg.2017.202. Epub 2017 Jul 18.

PMID:
28719593
29.

Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis.

Simon D, Page B, Vogel M, Bussmann C, Blanchard C, Straumann A, Simon HU.

Allergy. 2018 Jan;73(1):239-247. doi: 10.1111/all.13244. Epub 2017 Aug 6.

30.

Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey.

Vavricka SR, Spasojevic M, Rogler G, Schoepfer AM, Seibold F, Borovicka J, Frei P, Zeitz J, Greuter T, Manser C, Scharl M, Misselwitz B, Straumann A, Michetti P, Biedermann L; Swiss IBDnet.

Dig Dis. 2017;35(5):423-432. doi: 10.1159/000475494. Epub 2017 Jun 9.

31.

Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.

Vicari AP, Schoepfer AM, Meresse B, Goffin L, Léger O, Josserand S, Guégan N, Yousefi S, Straumann A, Cerf-Bensussan N, Simon HU, Chvatchko Y.

MAbs. 2017 Aug/Sep;9(6):927-944. doi: 10.1080/19420862.2017.1332553. Epub 2017 Jun 5.

32.

Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, Amil Dias J, Bove M, González-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodríguez-Sánchez J, Ravelli A, Ronkainen J, Santander C, Schoepfer AM, Storr MA, Terreehorst I, Straumann A, Attwood SE.

United European Gastroenterol J. 2017 Apr;5(3):335-358. doi: 10.1177/2050640616689525. Epub 2017 Jan 23. Review.

33.

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.

Vavricka SR, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N, Juillerat P, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Heinrich H, Manser CN, Safroneeva E, Raja Ali RA, Rogler G, Schoepfer AM, Greuter T; Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2017 Jul;23(7):1174-1181. doi: 10.1097/MIB.0000000000001109.

34.

Eosinophilic esophagitis: unclear roles of IgE and eosinophils.

Blanchard C, Simon D, Schoepfer A, Straumann A, Simon HU.

J Intern Med. 2017 May;281(5):448-457. doi: 10.1111/joim.12568. Epub 2016 Nov 7. Review.

35.

[Eosinophilic Esophagitis - Update - Pathogenesis, Diagnosis and Therapy].

von Arnim U, Miehlke S, Madisch A, Vieth M, Straumann A, Malfertheiner P.

Laryngorhinootologie. 2017 Jan;96(1):11-21. doi: 10.1055/s-0042-119417. Epub 2017 Feb 13. German.

PMID:
28192821
36.

Commentary: Collaborating to Achieve a Mutual Cybersecurity Advantage.

Hagestad B, Straumann A.

Biomed Instrum Technol. 2017 Jan-Feb;51(1):34-39. doi: 10.2345/0899-8205-51.1.34. No abstract available.

PMID:
28103101
37.

Comparison of different biopsy forceps models for tissue sampling in eosinophilic esophagitis.

Bussmann C, Schoepfer AM, Safroneeva E, Haas N, Godat S, Sempoux C, Simon HU, Straumann A.

Endoscopy. 2016 Dec;48(12):1069-1075. Epub 2016 Nov 4.

PMID:
27824401
38.

Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.

Greuter T, Bertoldo F, Rechner R, Straumann A, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Rogler G, Safroneeva E, Ali RAR, Braegger C, Heyland K, Mueller P, Nydegger A, Petit LM, Schibli S, Furlano RI, Spalinger J, Schäppi M, Zamora S, Froehlich F, Herzog D, Schoepfer AM, Vavricka SR; Swiss IBD Cohort Study Group.

J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):200-206. doi: 10.1097/MPG.0000000000001455.

39.

Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.

Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A, Nydegger A, Vavricka SR, Moradpour D, Schoepfer AM; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2017 Jan;29(1):91-97.

40.

Endoscopy in eosinophilic esophagitis: within or beyond the reach of the endoscope?

Straumann A.

Endoscopy. 2016 Sep;48(9):785-6. doi: 10.1055/s-0042-108575. Epub 2016 Aug 29. No abstract available.

PMID:
27571584
41.

Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.

Schoepfer A, Safroneeva E, Straumann A.

Dig Dis. 2016;34(5):462-8. doi: 10.1159/000445201. Epub 2016 Jun 22. Review.

PMID:
27333298
42.

Acute Herpes Simplex Viral Esophagitis Occurring in 5 Immunocompetent Individuals With Eosinophilic Esophagitis.

Zimmermann D, Criblez DH, Dellon ES, Bussmann C, Pfeifer D, Froh M, Straumann A.

ACG Case Rep J. 2016 Apr 15;3(3):165-8. doi: 10.14309/crj.2016.38. eCollection 2016 Apr.

43.

Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders.

Dellon ES, Collins MH, Bonis PA, Leung J, Capocelli KE, Dohil R, Falk GW, Furuta GT, Menard-Katcher C, Gupta SK, Hirano I, Hiremath GS, Kagalwalla AF, Wershil BK, Liacouras CA, Muir AB, Mukkada VA, Putnam PE, Schoepfer AM, Straumann A, Wo JM, Yang GY, Rothenberg ME, Gonsalves N.

Clin Gastroenterol Hepatol. 2016 Dec;14(12):1842-1844. doi: 10.1016/j.cgh.2016.04.025. Epub 2016 Apr 22. No abstract available.

44.

Systematic Evaluation of Diagnostic Delay in Pediatric Inflammatory Bowel Disease.

Schoepfer AM, Vavricka S, Safroneeva E, Fournier N, Manser C, Frei P, Deltenre P, Rogler G, Straumann A, Ezri J, Nydegger A, Braegger C.

J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):245-247. doi: 10.1097/MPG.0000000000001238.

45.

A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families.

Straumann A, Blanchard C, Radonjic-Hoesli S, Bussmann Ch, Hruz P, Safroneeva E, Simon D, Schoepfer AM, Simon HU.

Allergy. 2016 Jun;71(6):889-900. doi: 10.1111/all.12879. Epub 2016 Apr 1.

PMID:
26970242
46.

Therapy: Positioning of dilation in eosinophilic oesophagitis.

Straumann A, Schoepfer A.

Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):192-4. doi: 10.1038/nrgastro.2016.38. Epub 2016 Mar 2. No abstract available.

PMID:
26931163
47.

Patient-Reported Outcomes in Eosinophilic Esophagitis and Achalasia.

Schoepfer A, Straumann A, Safroneeva E.

Curr Treat Options Gastroenterol. 2016 Mar;14(1):51-60. doi: 10.1007/s11938-016-0084-0.

PMID:
26831294
48.

Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity.

Simon D, Cianferoni A, Spergel JM, Aceves S, Holbreich M, Venter C, Rothenberg ME, Terreehorst I, Muraro A, Lucendo AJ, Schoepfer A, Straumann A, Simon HU.

Allergy. 2016 May;71(5):611-20. doi: 10.1111/all.12846. Epub 2016 Feb 25. Review.

PMID:
26799684
49.

Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.

Molina-Infante J, Bredenoord AJ, Cheng E, Dellon ES, Furuta GT, Gupta SK, Hirano I, Katzka DA, Moawad FJ, Rothenberg ME, Schoepfer A, Spechler SJ, Wen T, Straumann A, Lucendo AJ; PPI-REE Task Force of the European Society of Eosinophilic Oesophagitis (EUREOS).

Gut. 2016 Mar;65(3):524-31. doi: 10.1136/gutjnl-2015-310991. Epub 2015 Dec 18.

50.

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis.

Safroneeva E, Straumann A, Coslovsky M, Zwahlen M, Kuehni CE, Panczak R, Haas NA, Alexander JA, Dellon ES, Gonsalves N, Hirano I, Leung J, Bussmann C, Collins MH, Newbury RO, De Petris G, Smyrk TC, Woosley JT, Yan P, Yang GY, Romero Y, Katzka DA, Furuta GT, Gupta SK, Aceves SS, Chehade M, Spergel JM, Schoepfer AM; International Eosinophilic Esophagitis Activity Index Study Group.

Gastroenterology. 2016 Mar;150(3):581-590.e4. doi: 10.1053/j.gastro.2015.11.004. Epub 2015 Nov 14.

Supplemental Content

Loading ...
Support Center